After silencing PSMB8, reduced expression of TGFBR1 and TGFBR2 led to decreased phosphorylation of SMAD2/3 (Fig. 5h), which inhibited the malignant behavior of glioma cells (Fig. 5j). The gene discussed is SMAD2; the disease is central nervous system cancer.